| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |